Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial (2022)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1093/eurheartj/ehac472
- Subjects: INFARTO DO MIOCÁRDIO; VACINAÇÃO; PREVENÇÃO DE DOENÇAS; PACIENTES INTERNADOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European heart journal
- ISSN: 0195-668X
- Volume/Número/Paginação/Ano: v. 43, n. 41, Special Issue, p. 4378-4388, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FONSECA, Henrique Andrade R. et al. Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial. European heart journal, v. 43, n. 41, p. 4378-4388, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50463. Acesso em: 17 fev. 2026. -
APA
Fonseca, H. A. R., Furtado, R. H. M., Zimerman, A., Lemos, P. A., Franken, M., Monfardini, F., et al. (2022). Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial. European heart journal, 43( 41), 4378-4388. doi:10.1093/eurheartj/ehac472 -
NLM
Fonseca HAR, Furtado RHM, Zimerman A, Lemos PA, Franken M, Monfardini F, Pedrosa RP, Patriota R de LS, Passos LCS, Dall'orto FTC. Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial [Internet]. European heart journal. 2022 ; 43( 41): 4378-4388.[citado 2026 fev. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50463 -
Vancouver
Fonseca HAR, Furtado RHM, Zimerman A, Lemos PA, Franken M, Monfardini F, Pedrosa RP, Patriota R de LS, Passos LCS, Dall'orto FTC. Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial [Internet]. European heart journal. 2022 ; 43( 41): 4378-4388.[citado 2026 fev. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50463 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
Informações sobre o DOI: 10.1093/eurheartj/ehac472 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
